Lithocholate-A promising non-calcaemic calcitriol surrogate for promoting human osteoblast maturation upon biomaterials

Steroids

Volumn 74, Issue 12, 2009, Pages 963-970

  Mansell, Jason Peter ^a   Shorez, David ^a   Farrar, David ^b   Nowghani, Maryam ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b Smith and Nephew Research Centre   (United Kingdom)

Author keywords

Biomaterials; Differentiation; Lithocholic acid; Lysophosphatidic acid; Osteoblasts

Indexed keywords

ACETIC ACID DERIVATIVE; ALKALINE PHOSPHATASE; BIOMATERIAL; CALCITRIOL; EPIDERMAL GROWTH FACTOR; ESTER DERIVATIVE; FARNESOID X RECEPTOR; HYDROXYAPATITE; LITHOCHOLIC ACID; LITHOCHOLIC ACID A; LITHOCHOLIC ACID A ACETATE; LITHOCHOLIC ACID A ACETATE METHYL ESTER; LYSOPHOSPHATIDIC ACID; PREGNANE X RECEPTOR; TITANIUM; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BONE GRAFT; BONE MATURATION; BONE MINERALIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OSTEOBLAST; TIME;

ANIMALS; CALCITRIOL; CATTLE; CELL DIFFERENTIATION; CELL LINE; DURAPATITE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LITHOCHOLIC ACID; OSTEOBLASTS; PROSTHESES AND IMPLANTS; RECEPTORS, CALCITRIOL; TITANIUM; TRANSCRIPTION FACTOR AP-1;

EID: 70249085863     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2009.07.005     Document Type: Article

References (31)

1. van Driel M., Pols H.A.P., and van Leeuwen J.P.T.M. Osteoblast differentiation and control by vitamin D and vitamin D metabolites. Curr Pharmaceut Des 10 (2004) 2535-2555
2. 3 enhance human osteoblast differentiation and mineralisation. J Cell Biochem 99 (2006) 922-935
3. Berry J.L., Davies M., and Mee A.P. Vitamin D metabolism, rickets and osteomalacia. Semin. Musculoskelet Radiol 6 (2002) 173-182
4. Makishima M., Lu T.T., Xie W., Whitfield G.K., Domoto H., Evans R.M., et al. Vitamin D receptor as an intestinal bile acid sensor. Science 296 (2002) 1313-1316
5. Adachi R., Honma Y., Masuno H., Kawana K., Shimomura I., Yamada S., et al. Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative. J Lipid Res 46 (2005) 46-57
6. Horie A., Akimoto M., Tsumura H., Makishima M., Taketani T., Yamaguchi S., et al. Induction of differentiation of myeloid leukaemia cells in primary culture in response to lithocholic acid acetate, a bile acid derivative, and cooperative effects with another differentiation inducer, cotylenin A. Leuk Res 32 (2008) 1112-1123
7. Sun J., Mustafi R., Cerda S., Chumsangsri A., Xia Y.R., Li Y.Y.C., et al. Lithocholic acid down-regulation of NK-κB activity through vitamin D receptor in colonic cancer cells. J Steroid Biochem Mol Biol 111 (2008) 37-40
8. Ishizawa M., Matsunawa M., Adachi R., Uno S., Ikeda K., Masuno H., et al. Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcaemia. J Lipid Res 49 (2008) 763-772
9. Nehring J.A., Zierold C., and DeLuca H.F. Lithocholic acid can carry out in vivo functions of vitamin D. Proc Natl Acad Sci USA 104 (2007) 10006-10009
10. 3 on differentiation of a human osteosarcoma (MG-63). J Biol Chem 267 (1992) 8943-8949
11. Yarram S.J., Tasman C., Gidley J., Clare M., Sandy J.R., and Mansell J.P. Epidermal growth factor and calcitriol synergistically induce osteoblast maturation. Mol Cell Endocrinol 220 (2004) 9-20
12. 3 in stimulating human MG63 osteoblast maturation. Prost Lipid Med 80 (2006) 46-61
13. Kahlen J.P., and Carlberg C. Functional characterization of a 1,25-dihydroxyvitamin D3 receptor binding site found in the rat atrial natriuretic factor promoter. Biochem Biophys Res Commun 218 (1996) 882-886
14. Davies M., Robinson M., Smith E., Huntley S., Prime S.S., and Paterson I. Induction of an epithelial-mesenchymal transition in human immortal and malignant keratinocytes by TGF-β1 involves MAPK, Smad and AP-1 signalling pathways. J Cell Biochem 95 (2005) 918-931
15. Hirano F., Tanaka H., Makino Y., Okamoto K., Hiramoto M., Handa H., et al. Induction of the transcription factor AP-1 in cultured human colon adenocarcinoma cells following exposure to bile acids. Carcinogenesis 17 (1996) 427-433
16. Brown A.J., and Slatopolsky E. Vitamin D analogs: therapeutic applications and mechanisms for selectivity. Mol Aspects Med 29 (2008) 433-452
17. Adachi R., Shulman A.I., Yamamoto K., Shimomura I., Yamada S., Mangelsdorf D.J., et al. Structural determinants for vitamin D receptor response to endocrine and xenobiotic signals. Mol Endocrinol 18 (2004) 43-52
18. Choi M., Yamamoto K., Itoh T., Makishima M., Mangelsdorf D.J., Moras D., et al. Interaction between vitamin D receptor and vitamin D ligands: two-dimensional alanine scanning mutational analysis. Chem Biol 10 (2003) 261-270
19. Jurutka P.W., Thompson P.D., Whitfield K., Eichhorst K.R., Hall N., Dominguez C.E., et al. Molecular and functional comparison of 1,25-dihydroxyvitamin D3 and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4. J Cell Biochem 94 (2005) 917-943
20. 3 receptor: a network of coactivator interactions. Gene 246 (2000) 9-21
21. Fiorucci S., Rizzo G., Donini A.E., Distrutti L., and Santucci L. Targeting farnesoid X receptor for liver and metabolic disorders. Trends Mol Med 13 (2007) 298-309
22. Lehmann J.M., McKee D.D., Watson M.A., Willson T.M., Moore J.T., and Kliewer S.A. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 expression and cause drug interactions. J Clin Invest 102 (1998) 1016-1023
23. Karaaslan Y., Haznedaroglu S., and Ozturk M. Osteomalacia associated with carbamazepine/valproate. Ann Pharmacother 34 (2000) 264-265
24. O'Hare J.A., Duggan B., O'Driscoll D., and Callaghan N. Biochemical evidence for osteomalacia with carbamazepine therapy. Acta Neurol Scand 62 (1980) 282-286
25. Pacussi J.M., Robert A., Nguyen M., Walrant-Debray O., Garabedian M., Martin P., et al. Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest 115 (2005) 177-186
26. Haussler M.R., Whitfield G.K., Haussler C.A., Hsieh J.C., Thompson P.D., Selznick S.H., et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. JBMR 13 (1998) 325-349
27. Wagner E.F. Functions of AP1 (Fos/Jun) in bone development. Ann Rheum Dis 61 (2002) 40-42
28. Marie P.J. Transcription factors controlling osteoblastogenesis. Arch Biochem Biophys 473 (2008) 98-105
29. Takeshita A., Imai K., Kato S., Kitano S., and Hanazawa S. 1alpha,25-dehydroxyvitamin D3 synergism toward transforming growth factor-beta1-induced AP1 transcriptional activity in mouse osteoblastic cells via its nuclear receptor. J Biol Chem 273 (1998) 14738-14744
30. Chen A., Davis B.H., Bissonnette M., Scaglione-Sewell B., and Brasitus T.A. 1,25-Dihydroxyvitamin D(3) stimulates activator protein-1 dependent Caco-2 cell differentiation. J Biol Chem 274 (1999) 35505-35513
31. Johansen C., Iversen L., Ryborg A., and Kragballe K. 1alpha,25-dihydroxyvitamin D3 induced differentiation of cultured human keratinocytes is accompanied by a PKC-independent regulation of AP-1 DNA binding activity. J Invest Dermatol 114 (2000) 1174-1179